查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1470996

熱原測試市場：按產品類型、測試類型、最終用戶分類 - 2024-2030 年全球預測

Pyrogen Testing Market by Product Type (Assays, Kits, & Reagents, Instruments, Services), Test Type (Limulus Amoebocyte Lysate, Monocyte Activation Test, Rabbit Tests), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

熱原測試市場規模預計2023年為12.4億美元，2024年達到13.8億美元，預計2030年將達到26.8億美元，複合年成長率為11.64%。

熱原測試是生物技術、醫療設備和製藥業採用的重要程序，用於確保注射藥物、醫療設備和其他與人體直接接觸的產品的安全和品質。熱原是一種當攝入人體時會引起發燒的物質，即使是少量。這些物質包括細菌內毒素（其主要是革蘭氏陰性細菌細胞壁的成分），以及其他引起發熱反應的微生物和非微生物污染物。人們對藥品安全性和有效性的認知和警覺性不斷提高，導致人們更加關注包括熱原在內的污染物檢測。此外，世界各地衛生當局製定的嚴格法規和標準要求進行全面的熱原測試，這增加了對測試服務和產品的需求。然而，先進的熱原測試方法的成本很高並且可能令人望而卻步，特別是對於中小企業（SME）而言。此外，日益轉向非動物測試方法為合成和重組熱原測試的創新提供了重大機會。

主要市場統計
基準年[2023] 12.4億美元
預測年份 [2024] 13.8億美元
預測年份 [2030] 26.8億美元
複合年成長率（%） 11.64%

產品類型：對自動化、加速和增強測試過程的檢測、套件和試劑的需求增加

測定、套件和試劑專為特定測試技術而設計，例如鱟變形細胞裂解物 (LAL) 測試、單核細胞活化測試 (MAT) 測試和兔熱原測試 (RPT) 測試。這些產品提供檢測熱原的存在和濃度所需的生化和生物成分。熱原測試涉及的設備包括用於自動化、促進和增強測試過程的裝置和設備。此部分包括內毒素檢測系統、培養箱和光強度等專用設備。設備範圍從基本測試設備到支援高通量測試、提高靈敏度並確保準確性的先進自動化系統。熱原檢測服務涵蓋專業實驗室和公司提供的服務。這些服務範圍從端到端熱原測試到研究設計和法規遵循諮詢。該服務適用於由於測試複雜性、需要專業知識或實驗室能力限制而外包熱原測試的組織。

最終用戶：生技公司對熱原測試的需求增加

生物技術公司處於開發治療和診斷解決方案的前沿，通常採用新型生物藥品。在這些情況下，熱原測試可確保這些生物製藥不含會引起發燒的污染物。這些公司最擔心的是重組蛋白、疫苗和細胞治療藥物可能受到污染，導致患者發燒反應。這些公司傾向於青睞創新、靈敏的測試，例如單核細胞活化測試 (MAT)，該測試可檢測傳統細菌內毒素以外更廣泛的熱原。醫療設備公司將熱原測試作為產品安全評估的重要組成部分。與人體直接接觸的設備，特別是那些用於血管內或鞘內使用的設備，如果受到污染，就有引起發燒反應的風險。這些公司面臨的主要挑戰是確保從簡單的手術器械到複雜的植入的各種器械的無菌性和無熱原性。生產各種藥品（包括腸外輸液）的製藥公司必須確保其產品無熱原，以防止對患者產生副作用。由於生產的藥品數量龐大且種類繁多，該行業是熱原測試服務最廣泛的用戶。

區域洞察

美洲，特別是美國和加拿大，是熱原測試的重要市場。美洲市場得益於先進的醫療基礎設施、嚴格的監管政策以及大型製藥和生物技術公司的存在。美國因其強大的研究生態系統而脫穎而出，可帶來創新的測試解決方案。該市場受到 FDA 法規的支持，這些法規要求對所有注射和植入式醫療設備進行嚴格的熱原測試。歐盟國家在監管標準和市場規模方面處於領先地位，採用歐洲藥典標準，強調透過嚴格的熱原測試確保產品安全。龐大的製藥工業基地和人們對產品安全意識的提高推動了熱原測試的需求。中東和非洲是具有成長潛力的新興市場。隨著醫療保健基礎設施和藥品生產能力的擴大，人們對熱原測試的興趣與日俱增。由於中國、日本和印度等國家製藥業的擴張，亞太地區的熱原測試市場正在快速成長。該地區對醫療保健和研究的投資不斷增加，重點是品管和安全標準。

FPNV定位矩陣

FPNV定位矩陣對於評估熱原測試市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對熱原測試市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.熱原測試市場的市場規模和預測是多少？

2.熱原測試市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.熱原測試市場的技術趨勢和法規結構是什麼？

4.熱原測試市場主要廠商的市場佔有率為何？

5.進入熱原檢測市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病和慢性病發生率增加
      • 增加藥品、生技藥品和醫療設備產品的產量
      • 世界各地衛生當局製定的嚴格法規和標準
    • 抑制因素
      • 與先進的熱原測試方法相關的高成本
    • 機會
      • 製藥和生技公司增加對研發活動的投資
      • 生物技術和熱原測試技術的技術進步
    • 任務
      • 與熱原測試相關的操作和道德問題
  • 市場區隔分析
    • 產品類型：對自動化、加速和增強測試過程的檢測、套件和試劑的需求不斷成長
    • 最終用戶：生技公司對熱原測試的需求增加
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章熱原測試市場：依產品類型

  • 測定、套件和試劑
  • 裝置
  • 服務

第7章按測試類型分類的熱原測試市場

  • 鱟變形蟲裂解物
  • 單核細胞活化試驗
  • 兔子測試
  • 重組連鎖試劑
  • 重組因子C

第8章熱原測試市場：依最終用戶分類

  • 生技公司
  • 醫療設備公司
  • 製藥公司

第9章 北美和南美熱原測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太熱原測試市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲熱原檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Charles River Laboratories 推出 Endsafe Trillium rCR 試劑盒，用於高效、非動物測試
    • Lonza 推出先進的快速 MAT 系統
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-035AB9C0DA61

[197 Pages Report] The Pyrogen Testing Market size was estimated at USD 1.24 billion in 2023 and expected to reach USD 1.38 billion in 2024, at a CAGR 11.64% to reach USD 2.68 billion by 2030.

Pyrogen testing is a critical procedure employed in the biotechnology, medical device, and pharmaceutical industries to ensure the safety and quality of injectable pharmaceuticals, medical devices, and other products that come in direct contact with the human body. Pyrogens are substances that, even in small amounts, can induce fever when introduced into the human body. These substances primarily include bacterial endotoxins, which are constituents of Gram-negative bacteria cell walls, and other microbial and non-microbial contaminants that elicit a pyrogenic response. Increased awareness and vigilance regarding drug safety and efficacy have heightened the focus on contaminant testing, including pyrogens. Moreover, stringent regulations and standards set by health authorities worldwide necessitate comprehensive pyrogen testing, fuelling demand for testing services and products. However, the high cost of advanced pyrogen testing methods can be prohibitive, especially for small and medium-sized enterprises (SMEs). Furthermore, the growing shift towards animal-free testing methods presents significant opportunities for innovation in synthetic and recombinant pyrogen testing methods.

KEY MARKET STATISTICS
Base Year [2023] USD 1.24 billion
Estimated Year [2024] USD 1.38 billion
Forecast Year [2030] USD 2.68 billion
CAGR (%) 11.64%

Product Type: Increasing demand of assays, kits, & reagents to automate, facilitate, or enhance the testing processes

Assays, kits, and reagents are designed for specific testing methodologies, such as the Limulus Amebocyte Lysate (LAL) test, Monocyte Activation Test (MAT), and Rabbit Pyrogen Test (RPT), among others. These products provide the biochemical and biological components necessary for detecting the presence and concentration of pyrogens. Instrumentation in pyrogen testing encompasses the devices and equipment used to automate, facilitate, or enhance the testing processes. This segment includes endotoxin detection systems, incubators, and spectrophotometers, among other specialized apparatuses. Instruments range from basic laboratory equipment to sophisticated automated systems that handle high-throughput testing, enhance sensitivity, and ensure precision. The pyrogen testing services cover the offerings provided by specialized laboratories and companies. These services range from end-to-end pyrogen testing to consultation on test design and regulatory compliance. Services cater to organizations that outsource pyrogen testing due to the high complexity of tests, the need for specialized expertise, or constraints in laboratory capacity.

End-User: Increasing demand of pyrogen testing across biotechnology companies

Biotechnology companies are at the forefront of developing therapeutic and diagnostic solutions, often employing novel biological agents. In this context, pyrogen testing ensures these biological products are free from fever-inducing contaminants. The primary concern for these companies is the potential contamination of recombinant proteins, vaccines, and cell therapies, which can provoke pyrogenic responses in patients. These entities tend to prefer innovative, sensitive testing methods such as the Monocyte Activation Test (MAT), which detect a broader range of pyrogens beyond the traditional bacterial endotoxins. Medical device companies incorporate pyrogen testing as a pivotal part of product safety assessments. Devices that come into direct contact with the human body, especially those intended for intravascular or intrathecal use, risk causing pyrogenic reactions if contaminated. The primary challenge for these companies is ensuring the sterility and non-pyrogenicity of a vast array of devices, from simple surgical instruments to complex implants. Pharmaceutical companies producing a wide range of medicinal products, including parenteral solutions, must ensure their products are pyrogen-free to prevent adverse patient reactions. This sector is the most extensive user of pyrogen testing services, given the vast quantities and varieties of drugs produced.

Regional Insights

The Americas, particularly the United States and Canada, represent a substantial market for pyrogen testing. The Americas market is attributed to the advanced healthcare infrastructure, strict regulatory policies, and the presence of key pharmaceutical and biotechnology companies. The United States stands out with its robust research ecosystem, leading to innovative testing solutions. The market is buoyed by FDA regulations that mandate rigorous pyrogen testing for all injectable and implantable medical devices. The EU countries are leading in regulatory standards and market size with the adoption of the European Pharmacopoeia standards, which underscores the commitment to ensuring product safety through rigorous pyrogen testing. The demand for pyrogen testing is driven by a large pharmaceutical industry base and heightened awareness regarding product safety. The Middle East and Africa present a nascent market with growing potential. The interest in pyrogen testing is increasing with the expansion of healthcare infrastructure and pharmaceutical manufacturing capabilities. The Asia Pacific region is witnessing rapid growth in the pyrogen testing market driven by expanding pharmaceutical industries in countries including China, Japan, and India. The region benefits from increasing investments in healthcare and research, coupled with a heightened focus on quality control and safety standards.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pyrogen Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pyrogen Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pyrogen Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Associates of Cape Cod, Inc., bioMerieux SA, Charles River Laboratories International, Inc., Corning Incorporated, Ellab A/S by Novo Nordisk A/S, Eurofins Scientific SE, FUJIFILM Corporation, GenScript Biotech Corporation, Indoor Biotechnologies, Inc., Lonza Group, MAT BioTech BV, Merck KGaA, Microcoat Biotechnologie GmbH, Minerva Analytix GmbH by Dilarus GmbH, Nelson Laboratories, LLC by Sotera Health, North American Science Associates, LLC, Pacific BioLabs, Solvias AG, Steris PLC, Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pyrogen Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Assays, Kits, & Reagents
    • Instruments
    • Services
  • Test Type
    • Limulus Amoebocyte Lysate
      • Chromogenic Tests
      • Gel Clot Tests
      • Turbidimetric Tests
    • Monocyte Activation Test
    • Rabbit Tests
    • Recombinant Cascade Reagent
    • Recombinant Factor C
  • End-User
    • Biotechnology Companies
    • Medical Device Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pyrogen Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pyrogen Testing Market?

3. What are the technology trends and regulatory frameworks in the Pyrogen Testing Market?

4. What is the market share of the leading vendors in the Pyrogen Testing Market?

5. Which modes and strategic moves are suitable for entering the Pyrogen Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of infectious diseases and chronic diseases
      • 5.1.1.2. Increasing production of pharmaceuticals, biologics, and medical devices products
      • 5.1.1.3. Stringent regulations and standards set by health authorities worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the advanced pyrogen testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D activities by pharmaceutical and biotechnology companies
      • 5.1.3.2. Technological advancements in biotechnology and pyrogen testing technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Operational and ethical concerns associated with the pyrogen testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing demand of assays, kits, & reagents to automate, facilitate, or enhance the testing processes
    • 5.2.2. End-User: Increasing demand of pyrogen testing across biotechnology companies
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Pyrogen Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Assays, Kits, & Reagents
  • 6.3. Instruments
  • 6.4. Services

7. Pyrogen Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Limulus Amoebocyte Lysate
  • 7.3. Monocyte Activation Test
  • 7.4. Rabbit Tests
  • 7.5. Recombinant Cascade Reagent
  • 7.6. Recombinant Factor C

8. Pyrogen Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Medical Device Companies
  • 8.4. Pharmaceutical Companies

9. Americas Pyrogen Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pyrogen Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pyrogen Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Charles River Laboratories Launches Endosafe Trillium rCR Cartridge for Efficient, Animal-Free Testing
    • 12.3.2. Lonza Introduces Advanced Rapid MAT Systems
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PYROGEN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. PYROGEN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PYROGEN TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 336. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 344. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
  • TABLE 352. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE